Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

New β-glucan inhibitors as antifungal drugs.

Hector RF, Bierer DE.

Expert Opin Ther Pat. 2011 Oct;21(10):1597-610. doi: 10.1517/13543776.2011.603899. Epub 2011 Jul 25. Review.

PMID:
21787240
2.

The public health impact of coccidioidomycosis in Arizona and California.

Hector RF, Rutherford GW, Tsang CA, Erhart LM, McCotter O, Anderson SM, Komatsu K, Tabnak F, Vugia DJ, Yang Y, Galgiani JN.

Int J Environ Res Public Health. 2011 Apr;8(4):1150-73. doi: 10.3390/ijerph8041150. Epub 2011 Apr 15. Review.

3.

Measuring cellular immunity in coccidioidomycosis: the time is now.

Ampel NM, Hector RF.

Mycopathologia. 2010 Jun;169(6):425-6. doi: 10.1007/s11046-010-9285-6. Epub 2010 Feb 16. No abstract available.

PMID:
20157783
4.

Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).

Johnson SM, Lerche NW, Pappagianis D, Yee JL, Galgiani JN, Hector RF.

Ann N Y Acad Sci. 2007 Sep;1111:290-300. Epub 2007 Mar 8.

PMID:
17347333
6.

An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.

Hector RF.

Clin Tech Small Anim Pract. 2005 Nov;20(4):240-9. Review.

PMID:
16317914
7.
8.

Coccidioidomycosis--a fungal disease of the Americas.

Hector RF, Laniado-Laborin R.

PLoS Med. 2005 Jan;2(1):e2. Review. No abstract available.

9.

Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes.

Luo J, Cheung J, Yevich EM, Clark JP, Tsai J, Lapresca P, Ubillas RP, Fort DM, Carlson TJ, Hector RF, King SR, Mendez CD, Jolad SD, Reaven GM.

J Pharmacol Exp Ther. 1999 Feb;288(2):529-34.

PMID:
9918555
10.

Efficacy of nikkomycin Z in the treatment of murine histoplasmosis.

Graybill JR, Najvar LK, Bocanegra R, Hector RF, Luther MF.

Antimicrob Agents Chemother. 1998 Sep;42(9):2371-4.

11.

Comparison of topical administration of clotrimazole through surgically placed versus nonsurgically placed catheters for treatment of nasal aspergillosis in dogs: 60 cases (1990-1996).

Mathews KG, Davidson AP, Koblik PD, Richardson EF, Komtebedde J, Pappagianis D, Hector RF, Kass PH.

J Am Vet Med Assoc. 1998 Aug 15;213(4):501-6.

PMID:
9713532
12.

Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata).

Luo J, Chuang T, Cheung J, Quan J, Tsai J, Sullivan C, Hector RF, Reed MJ, Meszaros K, King SR, Carlson TJ, Reaven GM.

Eur J Pharmacol. 1998 Apr 3;346(1):77-9.

PMID:
9617755
13.

Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.

Bierer DE, Fort DM, Mendez CD, Luo J, Imbach PA, Dubenko LG, Jolad SD, Gerber RE, Litvak J, Lu Q, Zhang P, Reed MJ, Waldeck N, Bruening RC, Noamesi BK, Hector RF, Carlson TJ, King SR.

J Med Chem. 1998 Mar 12;41(6):894-901.

PMID:
9526563
14.

Compounds active against cell walls of medically important fungi.

Hector RF.

Clin Microbiol Rev. 1993 Jan;6(1):1-21. Review.

15.

Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.

Hector RF, Schaller K.

Antimicrob Agents Chemother. 1992 Jun;36(6):1284-9.

16.

Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.

Pappagianis D, Zimmer BL, Theodoropoulos G, Plempel M, Hector RF.

Antimicrob Agents Chemother. 1990 Jun;34(6):1132-8.

17.
18.

Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis.

Hector RF, Zimmer BL, Pappagianis D.

Antimicrob Agents Chemother. 1990 Apr;34(4):587-93.

20.

The use of flow cytometry to monitor chitin synthesis in regenerating protoplasts of Candida albicans.

Hector RF, Braun PC, Hart JT, Kamarck ME.

J Med Vet Mycol. 1990;28(1):51-7.

PMID:
2194018
21.

Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody.

Hector RF, Collins MS, Pennington JE.

J Infect Dis. 1989 Sep;160(3):483-9.

PMID:
2760499
22.

Microtiter method for MIC testing with spherule-endospore-phase Coccidioides immitis.

Hector RF, Zimmer BL, Pappagianis D.

J Clin Microbiol. 1988 Dec;26(12):2667-8.

23.

Effect of cerulenin and sodium butyrate on chitin synthesis in Candida albicans.

Braun PC, Hector RF, Kamark ME, Hart JT, Cihlar RL.

Can J Microbiol. 1987 Jun;33(6):546-50.

PMID:
2957042
26.

Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.

Collins MS, Tsay GC, Hector RF, Roby RE, Dorsey JH.

Antibiot Chemother (1971). 1987;39:222-32. No abstract available.

PMID:
3118784
28.
29.
30.
31.
32.

Immunodeficient CBA/N mice respond effectively to Candida albicans.

Carrow EW, Hector RF, Domer JE.

Clin Immunol Immunopathol. 1984 Dec;33(3):371-80.

PMID:
6388927
33.

High-pressure liquid chromatographic assay of Bay n 7133 in human serum.

Fasching CE, Hughes CE, Hector RF, Peterson LR.

Antimicrob Agents Chemother. 1984 May;25(5):596-8.

34.
35.
36.

Immune responses to Candida albicans in genetically distinct mice.

Hector RF, Domer JE, Carrow EW.

Infect Immun. 1982 Dec;38(3):1020-8.

38.

Immunological relatedness among Candida albicans and other pathogenic Candida species.

Hector RF, Lyon FL, Domer JE.

Infect Immun. 1981 Dec;34(3):844-50.

Supplemental Content

Loading ...
Support Center